Request an Invitation
CardioExchange has 4,577 members
Merck Returns to Cardiome All Rights to Atrial Fibrillation Drug Vernakalant
Merck and Cardiome announced today that Merck is returning to Cardiome all marketing and development rights for the atrial fibrillation (AF) drug vern...
To continue reading, please log in to the right or
request an invitation
Member Sign In
Stay Signed In
Forgot your password?
Request an invitation
to become a CardioExchange member.
Copyrighted © 2013, Massachusetts Medical Society
The content of this site is intended for health care professionals.